A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
Roswell Park Cancer Institute
Cellectar Biosciences, Inc.
Rigshospitalet, Denmark
Eli Lilly and Company
Dana-Farber Cancer Institute
Acerta Pharma BV
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
City of Hope Medical Center
Fred Hutchinson Cancer Center
City of Hope Medical Center
Dartmouth-Hitchcock Medical Center
Karyopharm Therapeutics Inc
Scripps Health
Columbia University
Amgen
Northwestern University
Barbara Ann Karmanos Cancer Institute
Roswell Park Cancer Institute
Barbara Ann Karmanos Cancer Institute
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Eli Lilly and Company
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
University of Maryland, Baltimore